Telisotuzumab vedotin (ADC)
Product Sizes
1 mg
£1772.00
DHC34299-1MG
5 mg
£6137.00
DHC34299-5MG
About this Product
- SKU:
- DHC34299
- Additional Names:
- ABBV-399
- translate.label.attr.clone:
- Telisotuzumab vedotin
- Clonality:
- Recombinant Monoclonal
- Concentration:
- 1 mg/ml
- Extra Details:
- Telisotuzumab vedotin is an ADC consisting of a cMET-directed antibody and Monomethyl auristatin E (MMAE) that has recently obtained the breakthrough therapy designation (BTD) for the treatment of patients with c-Met overexpression, advanced/metastatic wild-type (WT) epithelial growth factor receptor (EGFR) non-squamous non-small cell lung cancer (sqNSCLC) that progressed during or after platinum-based chemotherapy.
- Immunogen:
- cMet
- Physical State:
- Liquid
- Purity:
- >90% as determined by sec.
- Purification:
- Ion Exchange
- Reactivities:
- Human
- Shipping Conditions:
- Blue Ice
- Storage Conditions:
- -20[o]C Avoid freeze/thaw cycles., 2-8[o]C Avoid freeze/thaw cycles., -70[o]C Avoid freeze/thaw cycles.
- Supplier:
- AntibodySystem
- Type:
- Antibody: Recombinant Antibodies
